James B. Weissman
2020
Compensation breakdown
Non-Equity Incentive Plan | $195,300 |
---|---|
Option Awards | $1,882,576 |
Salary | $434,000 |
Stock Awards | $781,268 |
Other | $19,468 |
Total | $3,312,612 |
Weissman received $1.9M in option awards, accounting for 57% of the total pay in 2020.
Weissman also received $195.3K in non-equity incentive plan, $434K in salary, $781.3K in stock awards and $19.5K in other compensation.
Rankings
In 2020, James B. Weissman's compensation ranked 3,524th out of 13,090 executives tracked by ExecPay. In other words, Weissman earned more than 73.1% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 3,524 out of 13,090 | 73rd |
Division Manufacturing | 1,378 out of 5,624 | 76th |
Major group Chemicals And Allied Products | 518 out of 2,257 | 77th |
Industry group Drugs | 449 out of 1,957 | 77th |
Industry Pharmaceutical Preparations | 335 out of 1,462 | 77th |
Pay ratio
James B. Weissman's Pay | $3,312,612 |
---|---|
Median Employee's Pay | $311,375 |
Pay Ratio | 11to 1 |
In 2020, the annual total compensation of James B. Weissman was $3,312,612.
The annual total compensation of the median employee at Dicerna Pharmaceuticals was $311,375.
The ratio of James B. Weissman's pay to the pay of median employee was therefore 11 to one.
Weissman's colleagues
We found six more compensation records of executives who worked with James B. Weissman at Dicerna Pharmaceuticals in 2020.
2020
Douglas Fambrough
Dicerna Pharmaceuticals
Chief Executive Officer
2020
Ralf Rosskamp
Dicerna Pharmaceuticals
Chief Medical Officer
2020
John Green
Dicerna Pharmaceuticals
Chief Financial Officer
2020
Bob Brown
Dicerna Pharmaceuticals
Chief Scientific Officer
2020
Shreeram Aradhye
Dicerna Pharmaceuticals
Chief Medical Officer
2020
Douglas Pagán
Dicerna Pharmaceuticals